Delaware Board of Pharmacy June 19, 2013 Meeting Agenda

PUBLIC MEETING NOTICE: BOARD OF PHARMACY
DATE AND TIME: Wednesday, June 19, 2013 9:30 a.m.
PLACE: 861 Silver Lake Boulevard, Dover, Delaware  Conference Room A , second floor of the Cannon Building

AGENDA (amended items are marked with an asterisk*)  
1.0 Call to Order
2.0 Review and Approval of Minutes
2.1 Meeting Minutes – May 15, 2013
3.0 President’s Report
4.0 Unfinished Business
 4.1 Complaint Status
  13-03-11 – Assigned to Hearing Officer   13-09-11 – Assigned to Hearing Officer   13-12-11 – Forwarded to Office of Attorney General   13-19-11 – Forwarded to Office of Attorney General   13-02-12 – Forwarded to Office of Attorney General   13-03-12 – Closed   13-04-12 – Assigned   13-05-12 – Assigned   13-07-12 – Assigned   13-09-12 – Assigned   13-01-13 – Forwarded to Office of Attorney General   13-02-13 – Assigned   13-03-13 – Assigned   13-04-13 – Assigned   13-05-13 – Assigned   13-06-13 – Forwarded to Office of Attorney General   13-07-13 – Assigned   13-08-13 – Assigned   13-09-13 – Assigned   13-10-13 – Assigned   13-11-13 – Assigned
 4.2 Prescription Monitoring Program (PMP) Update

4.3 Deliberation on Public Comments Received on Proposed Regulations  

 4.4 Discussion of Patient Counseling Regulation and Statute Language  

5.0 New Business 

 5.1 Pharmacist Licensure Approval Ratifications 

 5.1.1 Rina Kelley  5.1.2 Na’Teka Shelton  5.1.3 Chad Forinash  5.1.4 David Dinh  5.1.5 Gary Sobocinski  

 5.2 Pharmacist Intern Licensure Approval Ratifications 

  5.2.1 Viha Dave   5.2.2 Robert Wright   5.2.3 Laura Wolfe     5.3 Facility Licensure Approval Ratifications 

 5.3.1 Non–Resident Pharmacies 

   5.3.1.1 Green Valley Drugs    5.3.1.2 Goot Nursing Home Pharmacy, Inc.    5.3.1.3 Walgreen Co.     5.3.1.4 Mead Square Pharmacy, Inc.    5.3.1.5 Prescription Dynamics, Inc.    5.3.1.6 Arrow Pharmacy Holdings, LLC    5.3.1.7 HomeChoice Partners, Inc.  

 5.3.2 Wholesale Distributors 

   5.3.2.1 DPT Laboratories, Ltd.    5.3.2.2 Antigen Laboratories    5.3.2.3 Watson Pharma, Inc.     5.3.2.4 Grifols USA, LLC  

  5.3.3 Retail Pharmacies 

   5.3.3.1 Delaware CVS pharmacy    5.3.3.2 CVS Pharmacy #6869  

  5.3.4 Medical Gas Dispensers  

   5.3.4.1 Tri County Medical Equipment & Supply    5.3.4.2 Personal Support Medical Suppliers  

 5.4 Pharmacist-In-Charge Interview 

  5.4.1 Vinaykumar Prajapati   5.4.2 Vikas Verma  

 5.5 Consultant Pharmacist Interview 

  5.5.1 Joshua Coffield 

Board of Pharmacy Agenda – June 19, 2013 Page 3     

6.0   Committee Reports 

 6.1 Legislative – Sandy Robinson, Howard Simon, Jay Galloway, Kim Robbins and David        Dryden  

 6.2 Continuing Education – Sandy Robinson and Joli Martini  

 6.3 Consumer Affairs – Matt Maher and Jay Galloway  

 6.4 Professional Liaisons – Sandy Robinson and Sandra Zaragoza  

6.5 Controlled Substance Liaisons – Howard Simon, Jay Galloway and David Dryden  

7.0 Committee Updates Regarding Proposed Regulations 

 7.1 USP 795 & 797 Committee – Sandy Robinson, Howard Simon, Alicia Kluger, Brenda Pavlic, Sandra Zaragoza, Hooshang Shanehsaz, Calvin Freedman & David Dryden  

 7.2 Immunization/Pen Needle Committee – Howard Simon, Kim Robbins, Mark Freebery and                David Dryden  

 7.3 Pharmacy Technician Registration Committee – Howard Simon, Matt Maher, Sandy   Robinson, Kim Robbins, Kevin Musto,   Maryanne Holzapfel and David Dryden  

8.0    Board Correspondence  

9.0 Executive Secretary and Inspection Report – David Dryden, Samantha Nettesheim and Alicia       Kluger  

10.0 Newsletter Updates  

11.0 Other Business before the Board (for discussion only)  

12.0 Public Comments  

13.0 Next Meeting – August 21, 2013  

14.0 Adjournment  

Please Take Note:  To assure consideration of an application at a meeting, the Board office must receive all of these items no later than 4:30 p.m. ten full working days before the meeting date: 

• Completed, signed and notarized application form, 

• Fee payment, and 

• All required documentation. A final amended agenda will be published to reflect any items received after the original agenda is posted.    

Unforeseen circumstances may result in a meeting being cancelled due to a lack of quorum. Pursuant to 29 Delaware Code , Section 10004(e)(2), the Board shall pre-announce or pre-publish all Executive Sessions; however, such agenda shall be subject to change to include additional items including Executive Sessions which arise at the time of the body’s meeting. 

MEMBERS:  PLEASE CALL THE BOARD OFFICE AT 302-744-4500 OR EMAIL customerservice.dpr@state.de.us  IMMEDIATELY IF YOU CANNOT ATTEND THE MEETING.  THANK YOU.